3billion
3billion, Inc. develops technology for rare disease drug discovery using bioinformatics and machine learning technology. The company focuses on developing methods for novel drug target discovery, drug candidate generation, and safety assessment. It offers genetic and biomolecular testing services related to the analysis of biologic samples of patients suspected to have rare genetic disorders, as … Read more
3billion (394800) - Total Assets
Latest total assets as of March 2025: ₩32.58 Billion KRW
Based on the latest financial reports, 3billion (394800) holds total assets worth ₩32.58 Billion KRW as of March 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
3billion - Total Assets Trend (2021–2024)
This chart illustrates how 3billion’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
3billion - Asset Composition Analysis
Current Asset Composition (December 2024)
3billion's total assets of ₩32.58 Billion consist of 86.4% current assets and 13.6% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩11.66 Billion | 38.6% |
| Accounts Receivable | ₩1.03 Billion | 3.4% |
| Inventory | ₩221.90 Million | 0.7% |
| Property, Plant & Equipment | ₩2.79 Billion | 9.2% |
| Intangible Assets | ₩122.73 Million | 0.4% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how 3billion's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: 3billion's current assets represent 86.4% of total assets in 2024, an increase from 84.7% in 2021.
- Cash Position: Cash and equivalents constituted 38.6% of total assets in 2024, up from 22.9% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is cash and equivalents at 38.6% of total assets.
3billion Competitors by Total Assets
Key competitors of 3billion based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
USA | $2.22 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $7.59 Billion |
|
ESSA Pharma Inc
NASDAQ:EPIX
|
USA | $110.50 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
3billion - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - 3billion generates 0.19x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - 3billion is currently not profitable relative to its asset base.
3billion - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 9.49 | 9.73 | 9.73 |
| Quick Ratio | 9.35 | 9.48 | 9.48 |
| Cash Ratio | 4.10 | 7.40 | 7.40 |
| Working Capital | ₩22.17 Billion | ₩ 12.69 Billion | ₩ 12.69 Billion |
3billion - Advanced Valuation Insights
This section examines the relationship between 3billion's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 7.81 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 32.2% |
| Total Assets | ₩30.22 Billion |
| Market Capitalization | $98.93K USD |
Valuation Analysis
Below Book Valuation: The market values 3billion's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: 3billion's assets grew by 32.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for 3billion (2021–2024)
The table below shows the annual total assets of 3billion from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩30.22 Billion | +32.18% |
| 2023-12-31 | ₩22.86 Billion | -17.36% |
| 2022-12-31 | ₩27.66 Billion | +34.35% |
| 2021-12-31 | ₩20.59 Billion | -- |